scispace - formally typeset
C

Clay F. Semenkovich

Researcher at Washington University in St. Louis

Publications -  200
Citations -  33711

Clay F. Semenkovich is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Insulin resistance & Fatty acid synthase. The author has an hindex of 70, co-authored 193 publications receiving 30175 citations. Previous affiliations of Clay F. Semenkovich include Rush University Medical Center & Baylor College of Medicine.

Papers
More filters
Book ChapterDOI

Diabetes Mellitus and Vascular Disease Risk

TL;DR: Despite the etiologic and pathogenic differences between NIDDM and IDDM, the chronic sequelae of both forms of diabetes are the same, and vascular disease, particularly coronary heart disease, is the major cause of morbidity and mortality in diabetic patients.
Journal ArticleDOI

Abstract 138: Sex Differences In Limb Ischemia Recovery Following Conditional Endothelial Overexpression Of Cept1

TL;DR: In this article , a gender difference in peripheral arterial expression and ischemic recovery following CEPT1transgene overexpression was found in diabetic women and men.
Journal ArticleDOI

Impact of N-Acetyl-Cysteine on Ischemic Stumps Following Major Lower Extremity Amputation

TL;DR: Postoperative NAC administration may improve amputation stump perfusion and healing in patients with CLTI and tissue perfusion defects at the time of amputation.
Journal ArticleDOI

93-OR: Hepatic Acyl-Protein Thioesterases Prevent Insulin Resistance

TL;DR: Semenkovich et al. as mentioned in this paper used acyl resin-assisted capture (acyl-RAC) to isolate palmitoylated proteins from APT KO livers followed by mass spectrometry.
Journal ArticleDOI

Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments

TL;DR: Findings highlight that mechanisms that influence atheroprogression in the carotid and lower extremities peripheral arteries are not homogenous and can be impacted by patient diabetes status and serum cholesterol profiles.